Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan;21(1):1-5.
doi: 10.1007/s10689-020-00220-2. Epub 2021 Jan 6.

Atypical choroidal nevus in a subject with a germline PALB2 pathogenic variant

Affiliations
Case Reports

Atypical choroidal nevus in a subject with a germline PALB2 pathogenic variant

Timothy W Grosel et al. Fam Cancer. 2022 Jan.

Abstract

Recent evidence suggests that PALB2 variants may increase risk for the development of uveal melanoma and uveal melanocytic neoplasms. Here we report a case of an atypical choroidal nevus in a patient with a personal history of cancer and pathogenic PALB2 germline variant. A 75-year-old white female presented with an elevated predominantly amelanotic choroidal lesion OS. On examination and ophthalmic imaging, the mass measured 8.8 mm × 6.5 mm × 1.5 mm. The mass showed predominantly medium to high reflectivity on diagnostic A-scan and acoustic hollowing on B-scan. OCT over the lesion showed no subretinal fluid. The patient has a personal history of breast cancer and gastric adenoma and a strong family history of cancer. The patient was found to have a pathogenic truncating variant in PALB2 (rs118203998 c.3549C > A, p.Y1183*). Together with our previous findings of pathogenic PALB2 variants in uveal melanoma patients, this new finding of an atypical choroidal nevus in a patient with a pathogenic PALB2 germline variant suggests that pathogenic PALB2 variants may be a risk factor for uveal melanocytic neoplasms. This finding warrants further assessment of the prevalence and progression of uveal melanocytic neoplasms in PALB2 pathogenic variant carriers.

Keywords: Atypical choroidal nevus; Germline; PALB2; Uveal melanoma.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest/Competing interests

The authors have no conflicts of interest to declare.

Figures

Fig. 1.
Fig. 1.
A. Fundus photograph of left eye with mildly elevated predominantly amelanotic choroidal mass superior temporal to fovea with overlying drusen and no orange pigment. B. Longitudinal B-scan of the lesion at recent visit demonstrating acoustic hollowing. C. OCT over the elevated choroidal lesion demonstrates no subretinal fluid. D. A-scan of lesion, showing thickness of 1.63 mm and predominantly medium to high internal reflectivity.
Fig 2.
Fig 2.
Pedigree of the proband. Proband (III-1) has personal history of breast cancer and atypical choroidal nevus. Proband’s father (II-2) had pancreatic cancer at age 66, and sister (III-3) had breast cancer at age 77. Two nieces also had breast cancer, at age 54 and 38 (IV-2, IV-3). Proband’s brother (III-2) had metastatic gastric cancer at age 61.

References

    1. Singh AD, Kalyani P, Topham A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology. 2005;112(10):1784–9. doi: 10.1016/j.ophtha.2005.06.011. - DOI - PubMed
    1. Shields CL, Dalvin LA, Ancona-Lezama D, Yu MD, Di Nicola M, Williams BK Jr., et al. CHOROIDAL NEVUS IMAGING FEATURES IN 3,806 CASES AND RISK FACTORS FOR TRANSFORMATION INTO MELANOMA IN 2,355 CASES: The 2020 Taylor R. Smith and Victor T. Curtin Lecture. Retina (Philadelphia, Pa). 2019;39(10):1840–51. doi: 10.1097/iae.0000000000002440. - DOI - PubMed
    1. Rai K, Pilarski R, Boru G, Rehman M, Saqr AH, Massengill JB, et al. Germline BAP1 alterations in familial uveal melanoma. Genes Chromosomes Cancer. 2017;56(2):168–74. doi: 10.1002/gcc.22424. - DOI - PMC - PubMed
    1. Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, et al. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide. J Natl Cancer Inst. 2018;110(12):1328–41. doi: 10.1093/jnci/djy171. - DOI - PMC - PubMed
    1. Ducy M, Sesma-Sanz L, Guitton-Sert L, Lashgari A, Gao Y, Brahiti N, et al. The Tumor Suppressor PALB2: Inside Out. Trends in biochemical sciences. 2019;44(3):226–40. doi: 10.1016/j.tibs.2018.10.008. - DOI - PubMed

Publication types

Substances